Ashley S. Harms
University of Alabama at Birmingham
H-index: 23
North America-United States
Top articles of Ashley S. Harms
Alpha-synuclein overexpression can drive microbiome dysbiosis in mice
bioRxiv
2024
Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease
Brain
2024/2
IFNγ drives neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy
Acta neuropathologica communications
2024/1/18
Central and peripheral innate and adaptive immunity in Parkinson’s disease
2023/11/8
Glial-targeted therapeutics for CNS disease: getting there from here
2023/7/3
Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease
Nature communications
2023/6/26
Disease mechanisms as subtypes: Inflammation in Parkinson disease and related disorders
2023/1/1
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Molecular Neurodegeneration
2022/12
IFNγ drives neuroinflammation and demyelination in a mouse model of multiple system atrophy
bioRxiv
2022/11/23
Is Tau the initial pathology in dopaminergic nigrostriatal degeneration? Studies in Parkinsonism and Parkinson’s disease
bioRxiv
2022/8/6
‘Seeding’the idea of early diagnostics in synucleinopathies
Brain
2022/2/1
SRI‐42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide‐induced neuroinflammation
Glia
2022/1
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
Brain
2021/7/1
Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease
npj Parkinson's Disease
2021/4/13